| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.03B | -13.0% |
| Cost of Revenue | $47.4M | -17.6% |
| Gross Profit | $983.1M | -12.8% |
| R&D Expense | $87.4M | -8.4% |
| SG&A Expense | $262.9M | -17.9% |
| Operating Income | $65.4M | +198.9% |
| Pre-tax Income | $62.5M | +211.4% |
| Income Tax | $18.7M | +211.5% |
| Net Income | $43.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $303.7M | -27.1% |
| Accounts Receivable | $33.1M | -9.9% |
| Current Assets | $366.4M | -26.0% |
| Total Assets | $1.68B | -8.2% |
| Current Liabilities | $222.4M | -4.0% |
| Long-term Debt | $497.7M | +0.2% |
| Stockholders' Equity | $927.4M | -12.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $59.6M | +18.0% |
| Financing Cash Flow | -$158.3M | -194.5% |
| +21.7% |
| EPS (Basic) | $0.96 | +1271.4% |
| EPS (Diluted) | $0.94 | +1242.9% |